People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Transave Inc | — | Biotechnology | Series A | $13.0M | $72.3M | 2009 |
Geert-Jan H.C. Mulder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Geert-Jan H.C. Mulder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard S. Kollender | 1 | 7 |
| Donald Hayden, Jr. | 1 | 3 |
| Alex Barkas | 1 | 3 |
| Mark G. Cipriano | 1 | 2 |
| Timothy Whitten | 1 | 1 |
| Walter Perkins | 1 | 1 |
| Renu Gupta | 1 | 1 |
| Stephen H.C. Kraus | 1 | 1 |
| Nicholas H.C. Gurreri | 1 | 1 |
| Robert H.C. Weisskoff | 1 | 1 |
| Michio Soga | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.